FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230611906> ?p ?o ?g. }

• W4230611906 abstract "Abstract Objective: To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based therapy. Methods: This was an open-label, single-arm and multicenter clinical trial. The ORR was the interim primary objective, and the DCR, AEs and QOL were the secondary objectives. The impact of factors on efficacy outcomes, the change trend of CA125 and the artificial platinum-free interval were exploratory endpoints. Results: Totally, 115 patients were enrolled in this study and included in the ITT population. Moreover, 101 patients were included in the safety population. The median follow-up time was 4 months (IQR 2–6). In the ITT population, the confirmed ORR was 37.4% (95% CI, 28.4%-46.4%), and the DCR was 65.2% (95% CI, 56.4%-74.1%). The previous response status to platinum-based chemotherapy and baseline CA125 levels were significantly correlated with the ORR. The ORR was significantly higher in patients with a CA125 decrease after the first cycle than in the patients with a CA125 increase. The most common grade 3 or higher AE was hand-foot syndrome (3 [3.0%] of 101 patients). No statistically significant differences existed between the baseline and the postbaseline questionnaires. Conclusions: For patients who experience platinum-resistant and platinum-refractory relapse, the use of PLD may be acceptable because of the associated satisfactory efficacy, low frequency of AEs and high patient QOL. Moreover, a low CA125 level at baseline and a reduction in CA125 after the first cycle are predictive factors for satisfactory efficacy." @default.
• W4230611906 created "2022-05-11" @default.
• W4230611906 creator A5000703553 @default.
• W4230611906 creator A5004094036 @default.
• W4230611906 creator A5012278873 @default.
• W4230611906 creator A5017116648 @default.
• W4230611906 creator A5024520134 @default.
• W4230611906 creator A5025463213 @default.
• W4230611906 creator A5026248787 @default.
• W4230611906 creator A5028616197 @default.
• W4230611906 creator A5030583882 @default.
• W4230611906 creator A5042973046 @default.
• W4230611906 creator A5046238628 @default.
• W4230611906 creator A5060071396 @default.
• W4230611906 creator A5060185369 @default.
• W4230611906 creator A5068588368 @default.
• W4230611906 creator A5069754727 @default.
• W4230611906 creator A5070378728 @default.
• W4230611906 creator A5076705744 @default.
• W4230611906 creator A5082242693 @default.
• W4230611906 creator A5086375750 @default.
• W4230611906 creator A5089296993 @default.
• W4230611906 date "2020-10-13" @default.
• W4230611906 modified "2023-09-29" @default.
• W4230611906 title "Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer" @default.
• W4230611906 doi "https://doi.org/10.21203/rs.3.rs-38992/v3" @default.
• W4230611906 hasPublicationYear "2020" @default.
• W4230611906 type Work @default.
• W4230611906 citedByCount "0" @default.
• W4230611906 crossrefType "posted-content" @default.
• W4230611906 hasAuthorship W4230611906A5000703553 @default.
• W4230611906 hasAuthorship W4230611906A5004094036 @default.
• W4230611906 hasAuthorship W4230611906A5012278873 @default.
• W4230611906 hasAuthorship W4230611906A5017116648 @default.
• W4230611906 hasAuthorship W4230611906A5024520134 @default.
• W4230611906 hasAuthorship W4230611906A5025463213 @default.
• W4230611906 hasAuthorship W4230611906A5026248787 @default.
• W4230611906 hasAuthorship W4230611906A5028616197 @default.
• W4230611906 hasAuthorship W4230611906A5030583882 @default.
• W4230611906 hasAuthorship W4230611906A5042973046 @default.
• W4230611906 hasAuthorship W4230611906A5046238628 @default.
• W4230611906 hasAuthorship W4230611906A5060071396 @default.
• W4230611906 hasAuthorship W4230611906A5060185369 @default.
• W4230611906 hasAuthorship W4230611906A5068588368 @default.
• W4230611906 hasAuthorship W4230611906A5069754727 @default.
• W4230611906 hasAuthorship W4230611906A5070378728 @default.
• W4230611906 hasAuthorship W4230611906A5076705744 @default.
• W4230611906 hasAuthorship W4230611906A5082242693 @default.
• W4230611906 hasAuthorship W4230611906A5086375750 @default.
• W4230611906 hasAuthorship W4230611906A5089296993 @default.
• W4230611906 hasBestOaLocation W42306119061 @default.
• W4230611906 hasConcept C121332964 @default.
• W4230611906 hasConcept C121608353 @default.
• W4230611906 hasConcept C126322002 @default.
• W4230611906 hasConcept C141071460 @default.
• W4230611906 hasConcept C142424586 @default.
• W4230611906 hasConcept C143998085 @default.
• W4230611906 hasConcept C197934379 @default.
• W4230611906 hasConcept C2776694085 @default.
• W4230611906 hasConcept C2780427987 @default.
• W4230611906 hasConcept C2908647359 @default.
• W4230611906 hasConcept C535046627 @default.
• W4230611906 hasConcept C61943457 @default.
• W4230611906 hasConcept C71924100 @default.
• W4230611906 hasConcept C87355193 @default.
• W4230611906 hasConcept C90924648 @default.
• W4230611906 hasConcept C99454951 @default.
• W4230611906 hasConceptScore W4230611906C121332964 @default.
• W4230611906 hasConceptScore W4230611906C121608353 @default.
• W4230611906 hasConceptScore W4230611906C126322002 @default.
• W4230611906 hasConceptScore W4230611906C141071460 @default.
• W4230611906 hasConceptScore W4230611906C142424586 @default.
• W4230611906 hasConceptScore W4230611906C143998085 @default.
• W4230611906 hasConceptScore W4230611906C197934379 @default.
• W4230611906 hasConceptScore W4230611906C2776694085 @default.
• W4230611906 hasConceptScore W4230611906C2780427987 @default.
• W4230611906 hasConceptScore W4230611906C2908647359 @default.
• W4230611906 hasConceptScore W4230611906C535046627 @default.
• W4230611906 hasConceptScore W4230611906C61943457 @default.
• W4230611906 hasConceptScore W4230611906C71924100 @default.
• W4230611906 hasConceptScore W4230611906C87355193 @default.
• W4230611906 hasConceptScore W4230611906C90924648 @default.
• W4230611906 hasConceptScore W4230611906C99454951 @default.
• W4230611906 hasLocation W42306119061 @default.
• W4230611906 hasLocation W42306119062 @default.
• W4230611906 hasLocation W42306119063 @default.
• W4230611906 hasOpenAccess W4230611906 @default.
• W4230611906 hasPrimaryLocation W42306119061 @default.
• W4230611906 hasRelatedWork W1967715255 @default.
• W4230611906 hasRelatedWork W1973891791 @default.
• W4230611906 hasRelatedWork W2164307258 @default.
• W4230611906 hasRelatedWork W2351476339 @default.
• W4230611906 hasRelatedWork W2410583709 @default.
• W4230611906 hasRelatedWork W2528057197 @default.
• W4230611906 hasRelatedWork W3047309708 @default.
• W4230611906 hasRelatedWork W4250083105 @default.
• W4230611906 hasRelatedWork W4310753606 @default.
• W4230611906 hasRelatedWork W4362706485 @default.
• W4230611906 isParatext "false" @default.
• W4230611906 isRetracted "false" @default.

• next